日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HIV Viral Suppression With Use of Long-Acting Antiretroviral Therapy in People With and Without Initial Viremia

使用长效抗逆转录病毒疗法抑制初始病毒血症患者和初始病毒血症患者体内的HIV病毒载量

Spinelli, Matthew A; Heise, Megan J; Gistand, Nathanial; Cox, Chesa; Grochowski, Janet; Oskarsson, Jon; Glidden, David V; Gandhi, Monica

Combating cardiovascular disease disparities: The potential role of artificial intelligence

应对心血管疾病差异:人工智能的潜在作用

Orakwue, Chisom J; Tajrishi, Farbod Zahedi; Gistand, Constance M; Feng, Han; Ferdinand, Keith C

Viral Suppression Rates at 48 Weeks in People With HIV Starting Long-Acting Cabotegravir/Rilpivirine With Initial Viremia

HIV感染者在接受长效卡博特韦/利匹韦林治疗48周后,初始病毒血症患者的病毒抑制率

Hickey, Matthew D; Gistand, Nathanael; Grochowski, Janet; Mayorga-Munoz, Francis; Imbert, Elizabeth; Szumowski, John D; Oskarsson, Jon; Shiels, Mary; Dilworth, Samantha; Appa, Ayesha; Havlir, Diane V; Gandhi, Monica; Christopoulos, Katerina

Tackling the Disproportionate Burden of Resistant Hypertension in US Black Adults

应对美国黑人成年人中不成比例的难治性高血压负担

Reddy, Tina K; Nasser, Samar A; Pulapaka, Anuhya V; Gistand, Constance M; Ferdinand, Keith C